Stemline Therapeutics (STML) – Short Sales
-
Stemline Therapeutics (STML) Comments on Pivotal BPDCN Trial, Patient Death; Says Cause Hasn't Been Determined
-
UPDATE: Stemline Therapeutics (STML) Investors Are Over-Reacting, Says Cowen
-
Back to STML Stock Lookup